Get more from your #FFPE samples.
Turn archival tissue into a discovery engine.

Sapient’s FFPE Proteomics measures 10,000+ proteins across key oncogenes, drug targets & pathways to unlock new #biomarker insights.

➡️ lnkd.in/gZpnpwgU

Marker of the Month ⚛️: Creatinine.
A key kidney biomarker linked to #CKD, #T2D, cardiovascular & liver disease, but limited for early detection. With our DynamiQ™ Engine, we examined its disease ties and related metabolic markers.
eBook ⬇️ sapient.bio/resources/cr...

It’s not every day you celebrate a U.S. patent-let alone two! 🎉 We hosted a #PatentParty to mark a major milestone for Sapient, recognizing inventions behind our rLC-MS pipeline that advance the scale and accuracy of #biomarkerdiscovery.

More on our awarded patents: lnkd.in/dRHk3EPx

Thank you to our engaged audience and the gracious hosts of the #PACTSummit for the opportunity for Dr. Jonathan Usuka to present on omics-driven innovations in drug discovery and development.

#AnalyticalChemistry #PACTS #MultiOmics #Discovery

Outliers & missing data in #omics can complicate #biocomputational analysis — but also uncover hidden insights. Sapient’s Shreya Gaddam & Cameron Lamoreaux share strategies to handle missingness & outliers in large-scale #proteomics & #metabolomics data.
🔗 sapient.bio/resources/bi...

Our team had great time last week at #BiomarkersandPrecisionMedicineUS2025! Awesome talks on #multiomics & how our DynamiQ database + biorepository advance biomarker research. Thanks to all who stopped by Booth & our poster on immune modulation in weight loss! #BiomarkersandPrecisionMedicine

Innovation alert! Sapient has been granted two U.S. patents for our novel #massspectrometry signal processing + data normalization tech - powering more accurate, scalable #biomarker discovery.
Inventors: Dr. MoJain, Dr. Saumya Tiwari, and Dr.Jeramie Watrous!
Read here: sapient.bio/resources/ma...

Great first day at #BIOMUK2025!

Big thanks to everyone who joined Dr. Mo Jain’s talk & plenary panel - and to those who stopped by our booth to chat #multiomics.

We’ll be back tomorrow, come see us at Booth 52!

#BiomarkersandPrecisionMedicine #OGPremed #BiomarkersUK

We're excited to join Alamar's Precision Biomarker Summit this week in San Diego! 🧬

Sapient’s Tao Long will share insights on inflammatory profiles in obesity and how #NULISAseq reveals cytokine changes post-GLP-1 therapy.

Still time to register:
🔗 alamarbio.com/precision-bi...

Get your Omics Brief: a short talk on big shifts in drug development—this time exploring novel insights from a large-scale #metabolomics study.

What can thousands of metabolic profiles reveal about health, disease, and drug response?

Watch now: sapient.bio/resources/me...

In this Bioanalysis Zone interview, Sapient Co-Founders Jeramie Watrous and Tao Long explore how we use #AI and machine learning to transform complex data into actionable decisions.

sapient.bio/resources/om...

#biomarkers #multiomics #omicsanalytics #datatoinsight

Proud to join the #ARGOnaut Club! Sapient is among the first to bring Alamar Biosciences' ARGO HT + NULISA in house to measure key cytokine/chemokine targets in #inflammation + #CNS. Meet our system “Phocus”! Want to learn more? Reach out. #proteinbiomarkers #NULISA #ARGOHT #cytokines

Explore the future of #companiondiagnostics in this 3-part #eBook on next-gen protein-based #CDx. Learn how #proteomics and mass spectrometry drive biomarker discovery, expand CDx potential, and enable faster clinical impact. Download now: sapient.bio/resources/co...

📣 Exciting announcement: Sapient's study detailing the application of our rLC-MS system for non-targeted metabolomics analysis in 26,042 plasma samples is now published!

See how this breakthrough study led to development of a metabolic aging clock: tinyurl.com/3bpurfhe

What is the 𝐝𝐚𝐫𝐤 𝐩𝐫𝐨𝐭𝐞𝐨𝐦𝐞 & what role does it plays in the manifestation & progression of diseases like #cancer?

See recent findings that reinforce why the #darkproteome is a critical new frontier to explore as part of #drugdevelopment: bit.ly/4drNGCZ

We're thrilled to announce the launch of 𝐃𝐲𝐧𝐚𝐦𝐢𝐐™ as our next-generation data insights engine for drug discovery & development!

See all the ways we use this deeply phenotyped #multiomics database for analysis of patient journeys, disease drivers & drug response, and request a #demo!

bit.ly/4d0ihYa

#Biopharma data innovation on display at #BioITWorld with Rancho BioSciences presenting our joint poster on "Bringing Together Multi-Omics and Real-World Data to Accelerate Insight Delivery for Biomarker Discovery and Drug Development".

➡️ Learn more about our partnership with Rancho: bit.ly/3Yx79wd